Unknown

Dataset Information

0

ICU Resource Use in Critically III Patients following Chimeric Antigen Receptor T-Cell Therapy.

ABSTRACT:

SUBMITTER: Brown ART 

PROVIDER: S-EPMC7560798 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Posttransplant chimeric antigen receptor therapy.
| S-EPMC5865610 | biostudies-literature
Unknown Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
| S-EPMC9325766 | biostudies-literature
Unknown Chimeric antigen receptor therapy for cancer.
| S-EPMC4120077 | biostudies-literature
Unknown Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults.
| S-EPMC7221263 | biostudies-literature
Unknown Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy.
| S-EPMC8579267 | biostudies-literature
Unknown Chimeric antigen receptor T-cell therapy for solid tumors.
| S-EPMC4849432 | biostudies-literature
Unknown Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy.
| S-EPMC3107373 | biostudies-literature
Unknown Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer.
| S-EPMC7019711 | biostudies-literature
Unknown Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.
| S-EPMC7893957 | biostudies-literature
Unknown Isolated Intraocular Relapse of Pediatric B-cell Precursor Acute Lymphoblastic Leukaemia Following Chimeric Antigen Receptor T-lymphocyte Therapy.
| S-EPMC7556410 | biostudies-literature